Guy Lemière
University of Antwerp
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Guy Lemière.
Tetrahedron | 2001
Tim Hugo Maria Jonckers; Bert U. W. Maes; Guy Lemière; Roger Dommisse
Abstract Palladium-catalyzed amination proved to be a valuable strategy for the selective introduction of aromatic and heteroaromatic amines, including aminopyridines and aminodiazines, on dichloropyridines. The use of mild amination conditions resulted in maximum selectivity and excellent base sensitive functional group tolerance.
Journal of Medicinal Chemistry | 2009
Ibrahim El Sayed; Pieter Van der Veken; Liene Dhooghe; Steven Hostyn; Gitte Van Baelen; Guy Lemière; Bert U. W. Maes; Paul Cos; Louis Maes; Jurgen Joossens; Achiel Haemers; Luc Pieters; Koen Augustyns
A series of chloro- and aminoalkylamino-substituted neocryptolepine (5-methyl-5H-indolo[2,3-b]quinoline) derivatives were synthesized and evaluated as antiplasmodial agents. The evaluation also included cytotoxicity (MRC5 cells), inhibition of beta-hematin formation, and DNA interactions (DNA-methyl green assay). Introduction of aminoalkylamino chains increased the antiplasmodial activity of the neocryptolepine core substantially. The most efficient compounds showed antiplasmodial activities in the nanomolar range. N(1),N(1)-Diethyl-N(4)-(5-methyl-5H-indolo[2,3-b]quinolin-8-yl)pentane-1,4-diamine 11c showed an IC(50) of 0.01 microM and a selectivity index of 1800.
Journal of The Chemical Society-perkin Transactions 1 | 1995
Guy Lemière; Mei Gao; Alex De Groot; Roger Dommisse; Josef Lepoivre; Luc Pieters; Volker Buss
The title compound has been synthesised in racemic form by a biomimetic reaction sequence. The two enantiomers were resolved by column chromatography of one of the synthetic intermediates. On the basis of CD results a tentative absolute configuration for the synthetic enantiomers and natural 3′,4-di-O-methylcedresin is proposed.
Chemical Communications | 2004
Kristof T. J. Loones; Bert U. W. Maes; Roger Dommisse; Guy Lemière
A new strategy for the synthesis of the title compounds via a regio- and chemoselective one-pot inter- and intramolecular Buchwald-Hartwig amination of 2-chloro-3-iodopyridine with aminoazines and -diazines is reported.
Tetrahedron | 2001
Bert U. W. Maes; Omar R'kyek; Janez Košmrlj; Guy Lemière; Eddy L. Esmans; Jef Rozenski; Roger Dommisse; Achiel Haemers
Abstract The synthesis of 4-aryl-5-methoxy-, 5-aryl-4-methoxy- and 4,5-diaryl-3(2H)-pyridazinones via Suzuki palladium-catalysed cross-coupling reactions with the corresponding chloro-3(2H)-pyridazinones is described.
Tetrahedron | 2000
Bert U. W. Maes; Guy Lemière; Roger Dommisse; Koen Augustyns; Achiel Haemers
The synthesis of 3-amino-6-(hetero)arylpyridazines via palladium catalyzed cross-coupling reactions (Suzuki, Stille) on 3-amino-6-chloropyridazine (1a) and 3-amino-6-iodopyridazine (1b) has been investigated. Comparison of the results shows that there is no need to start from 1b. An improved method for the synthesis of compound 1b from 1a is also described.
Bioorganic & Medicinal Chemistry | 2009
Gitte Van Baelen; Steven Hostyn; Liene Dhooghe; Pál Tapolcsányi; Péter Mátyus; Guy Lemière; Roger Dommisse; Marcel Kaiser; Reto Brun; Paul Cos; Louis Maes; Gyorgy Hajos; Zsuzsanna Riedl; Ildikó Nagy; Bert U. W. Maes; Luc Pieters
Based on the indoloquinoline alkaloids cryptolepine (1), neocryptolepine (2), isocryptolepine (3) and isoneocryptolepine (4), used as lead compounds for new antimalarial agents, a series of tricyclic and bicyclic analogues, including carbolines, azaindoles, pyrroloquinolines and pyrroloisoquinolines was synthesized and biologically evaluated. None of the bicyclic compounds was significantly active against the chloroquine-resistant strain Plasmodium falciparum K1, in contrast to the tricyclic derivatives. The tricyclic compound 2-methyl-2H-pyrido[3,4-b]indole (9), or 2-methyl-beta-carboline, showed the best in vitro activity, with an IC(50) value of 0.45 microM against P. falciparum K1, without apparent cytotoxicity against L6 cells (SI>1000). However, this compound was not active in the Plasmodium berghei mouse model. Structure-activity relationships are discussed and compared with related naturally occurring compounds.
Tetrahedron | 2002
Pál Tapolcsányi; Gábor Krajsovszky; Romeo D. Ando; Peter Lipcsey; Gyula Horvath; Péter Mátyus; Zsuzsanna Riedl; Gyoergy Hajos; Bert U. W. Maes; Guy Lemière
Suzuki coupling of 5-chloro-2-methyl-6-phenylpyridazin-3(2H)-one, 6-chloro-1,3-dimethyluracil and 2-chloropyrazine with protected aminoaryl boronic acids resulted in the corresponding pivaloylaminophenyl diazines which were transformed to diazino-fused indole and cinnoline derivatives. Suzuki coupling of 5-amino-6-chloro-1,3-dimethyluracil with 2-formylphenyl boronic acid afforded a novel pyrimidoisoquinoline ring system in a one-pot reaction.
Tetrahedron | 2002
Zsuzsanna Riedl; Bert U. W. Maes; Katrien Monsieurs; Guy Lemière; Péter Mátyus; Gyoergy Hajos
Suzuki cross-coupling reaction of 2-alkyl(methyl and benzyl)-5-chloro-4-methoxy- and 2-alkyl(methyl and benzyl)-4-chloro-5-methoxypyridazin-3(2H)-ones with 2-formylphenylboronic acid afforded the corresponding biaryl products which were cyclized with ammonia to yield hitherto undescribed pyridazino[4,5-c]isoquinolinones. Removal of the N-benzyl protective group in position 2 yielded the unsubstituted tricyclic pyridazinones.
Tetrahedron | 2002
Bert U. W. Maes; Katrien Monsieurs; Kristof T. J. Loones; Guy Lemière; Roger Dommisse; Péter Mátyus; Zsuzsanna Riedl; Gyoergy Hajos
Abstract Easily accessible 2-substituted 4-aryl-5-methoxy- and 2-substituted 5-aryl-4-methoxypyridazin-3(2 H )-ones were transformed into the corresponding aryl-hydroxypyridazin-3(2 H )-ones by alkaline hydrolysis. The use of these compounds in the synthesis of 2-substituted 4,5-diarylpyridazin-3(2 H )-ones with two differently substituted aryl groups was investigated. Two aryl-hydroxypyridazin-3(2 H )-ones, 2-(2-benzyl-5-hydroxy-3-oxo-2,3-dihydropyridazin-4-yl)benzaldehyde and 2-(1-benzyl-5-hydroxy-6-oxo-1,6-dihydropyridazin-4-yl)benzaldehyde, were transformed into 2-benzyl-1 H -isochromeno[3,4- d ]pyridazine-1,6(2 H )-dione and 3-benzyl-3 H -isochromeno[3,4- d ]pyridazine-4,6-dione, respectively, via oxidation of the formyl group with KMnO 4 followed by lactonization.